期刊文献+

乳腺癌前哨淋巴结活检假阴性率的单中心多因素分析 被引量:28

Analysis of clinicopathological factors associated with false-negative rate of sentinel lymph nodebiopsy in breast cancer patients: experience of a single center
原文传递
导出
摘要 目的分析影响乳腺癌前哨淋巴结活检(SLNB)假阴性的临床病理学因素,探讨降低SLNB假阴性率的措施与方法。方法回顾性分析接受SLNB的2265例乳腺癌患者临床病理资料,对SLNB后接受腋窝淋巴结清除(ALND)的1228例患者进行分析,研究临床病理因素与SLNB假阴性率的相关性。结果SLNB的假阴性率为10.7%(73/683),准确率为94.1%(1155/1228),阴性预测值为88.2%(545/618)。单因素分析显示,SLNB假阴性率与肿瘤大小(P=0.030)、前哨淋巴结(SLN)检出数目(P〈0.001)和手术年份(P=0.001)有关,SLNB准确率与肿瘤大小(P=0.003)、SLN检出数目(P=0.003)和手术年份(P=0.015)有关。多因素分析显示,手术年份(P=0.034)和SLN检出数目(P=0.012)为SLNB假阴性率的独立影响因素。结论乳腺癌SLNB假阴性率与SLN检出数目和手术年份有关。严格人选指征、规范操作标准以及提高外科医生操作熟练程度是降低SLNB假阴性率的有效措施。 Objective The purpose of this study was to investigate the clinicopathologic factors associated with false-negative rate of sentinel lymph node biopsy (SLNB) in breast cancer, and to explore how to reduce the false-negative rate of SLNB. Methods The elinicopathologieal data of 2265 patients with invasive breast carcinoma who underwent sentinel lymph nodes biopsy (SLNB) in Shandong Cancer Hospital between November 1999 and December 2011 were retrospectively analyzed. We screened 1228 patients who received axillary lymph node dissection after SLNB, and studied the clinicopathologieal factors that could be associated with false-negative rate of SLNB. Results The false negative rate of this group was 10.7% (73/683), accuracy rate was 94. 1% (1155/1228), and negative predictive value was 88.2% (545/618). Clinical tumor size ( all P 〈 0.05 ), calendar year of surgery ( all P 〈 0.05 ) and numbers of detected SLNs ( all P 〈 0.05 ) were significantly related with false negative rate and accuracy rate of SLNB, determined by single factor analysis. Logistic regression model analysis showed that calendar year of surgery ( P = 0.034 ) and numbers of detected SLNs (P = 0.012) were independent predictive factors for the false negative rate of SLNB. Conclusions False negative rate and accuracy rate of SLNB are significantly related to the calendar year of surgery and number of detected SLNs. Strict case selection, standard operation procedure, increaseing numbers of detected SLNs, and improvement of the skill of operators are effective measures to reduce the false negative rate of SLNB.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2013年第5期389-393,共5页 Chinese Journal of Oncology
基金 中国前哨淋巴结活检多中心协作研究项目(CBCSG-001)
关键词 乳腺肿瘤 回顾性研究 前哨淋巴结活组织检查 淋巴转移 因素分析 统计学 Breast neoplasms Retrospective studies Sentinel lymph node biopsy Lymphatic metastasis Factor analysis, statistical
  • 相关文献

参考文献19

  • 1Takei H, Kurosumi M, Yoshida T, et al. Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies. Breast Cancer, 2010, 17:9-16.
  • 2Taras AR, Hendrickson NA, Lowe KA, et al. Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes. Am J Surg, 2010, 199:625-625.
  • 3Pesek S, Ashikaga T, Krag LE, et al. The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta- analysis. World J Surg, 2012, 36:2239-2251.
  • 4Goyal A, Newcombe RG, Chhabra A, et al. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer:results of the ALMANAC validation phase. Breast Cancer Res Treat, 2006, 99:203-208.
  • 5张建国,仲雷,李传乐,郭宝良,杨学伟.前哨淋巴结活检术检测乳腺癌腋窝淋巴结转移的效果评价[J].中华肿瘤杂志,2007,29(3):235-236. 被引量:4
  • 6Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer:a muhieenter validation study. N Engl J Med, 1998, 339 : 941-946.
  • 7Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oneology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oneol, 2007, 25 : 118-145.
  • 8Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta analysis. Cancer, 2006, 106:4-16.
  • 9郑刚,杨靖,左文述,于志勇,刘岩松,郑美珠,王圣芳.中国乳腺癌前哨淋巴结活检验证阶段研究结果的系统评价[J].中华医学杂志,2011,91(6):361-365. 被引量:36
  • 10Javan H, Gholami H, Assadi M, et al. The accuracy of sentinel node biopsy in breast cancer patients with the history of previous surgical biopsy of the primary lesion : systematic review and meta- analysis of the literature. Eur J Surg Oncol, 2012, 38:95-109.

二级参考文献32

  • 1徐晓明,赵祥生,周建农,唐金海,陈环球,张彤,周大庆,莫伏根,秦建伟,姜爱仁.前哨淋巴结检测在乳腺癌治疗中的意义[J].中华普通外科杂志,2004,19(8):494-495. 被引量:12
  • 2孙敏,魏守杰,衣龙海,左文述,王永胜,李廉,徐忠法,马恒,于志勇,郭洪亮,宋希林,王义会,杨秀荣.乳腺癌保留乳房治疗的临床研讨[J].中华外科杂志,1995,33(10):606-607. 被引量:23
  • 3江泽飞,姚开泰,宋三泰.乳腺癌治疗的新循证医学证据和临床实践[J].中华医学杂志,2005,85(43):3025-3027. 被引量:29
  • 4耿贯一.流行病学(第3版)[M].北京:人民卫生出版社,1994.72-80.
  • 5中华人民共和国药典编委会.中华人民共和国药典第二部(1995年版)[M].北京:化学工业出版社,1995.1024-1026.
  • 6Kra DN,Weaver DL,Alex JC,et al.Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol,1993,2:335-340.
  • 7Giuliano AE,Kirgan DM,Guenther M,et al.Lymphatic mapping and sentinel lymphadenectomy for breast cancer.J Ann Surg,1994,220:391-401.
  • 8Giuliano AE.Mapping a pathway for axillary staging:a personal perspective on the current status of sentinel lymph node dissection for breast cancer.Arch Surg,1999,134:195.
  • 9Choi SH,Barsky SH,Chang HR.Clinicopathologic ananlysis of sentinel lymph node mapping in early breast cancer.Breast J,2003,9:153.
  • 10Cody HS 3rd,Fey J,Akhurst T,et al.Complementarity of blue dye and isotope in sentinel node localization for breast cancer:univariate and multivarirate analysis of 966 procedures.Ann Surg Oncol,2001,8:13-19.

共引文献89

同被引文献266

引证文献28

二级引证文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部